Mar 17, 2026 by Seena HassounaWhat's Behind Naspers's Steady Exit From Remitly?Remitly, a global digital remittance provider, saw significant insider selling as disclosed in recent regulatory filings.
Mar 15, 2026 by Seena HassounaISCG vs. RZG: Which Small-Cap Growth ETF Fits Your Portfolio?Expense ratios, sector tilts, and portfolio breadth set these two small-cap growth ETFs apart for investors weighing their options.
Mar 15, 2026 by Seena HassounaCBIZ Insider Sale: Trust Move or Warning Sign?CBIZ, Inc., a major business services provider, reported significant insider selling amid a year of sharp share price declines.
Mar 15, 2026 by Seena HassounaA Healthcare Hedge Fund Just Added $24.5 Million in Immunovant Stock. Should you?This clinical-stage biotech develops antibody therapies targeting autoimmune diseases, with a lead candidate in Phase II trials.
Mar 13, 2026 by Seena HassounaA Hedge Fund Just Trimmed $2.7 Million of NCR Voyix. Should You Care?NCR Voyix delivers technology and managed services across retail, hospitality, and financial services for enterprise clients worldwide.
